Neuroone Medical Technologies (NMTC) Accumulated Expenses (2011 - 2026)

Neuroone Medical Technologies has disclosed Accumulated Expenses across 15 years of filings, most recently posting $755258.0 for Q1 2026.

• Quarterly Accumulated Expenses fell 11.42% year-over-year to $755258.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $755258.0 (down 11.42% YoY) and the FY2025 annual result came in at $1.3 million, up 9.18% from the prior year.
• Accumulated Expenses advanced to $755258.0 in Q1 2026, from $706112.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.3 million in Q3 2025 and bottomed at $41646.0 in Q1 2024.
• The 5-year median for Accumulated Expenses is $596940.0 (2023), against an average of $621554.4.
• Year-over-year, Accumulated Expenses plunged 93.02% in 2024 and jumped 1947.22% in 2025.
• Neuroone Medical Technologies' Accumulated Expenses stood at $473085.0 in 2022, then retreated by 28.03% to $340490.0 in 2023, then retreated by 5.27% to $322546.0 in 2024, then surged by 118.92% to $706112.0 in 2025, then grew by 6.96% to $755258.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $755258.0, $706112.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.